ARCHIVES

Xeloda As Effective As 5-FU/LV, Five-Year Survival Data Show

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

News Organizations Protest invitation-Only Press Conferences, Exclusion of Reporters

May 20, 1994

NCI Programs: Genetic Variations Discovered, Added to NCI Database

June 11, 1999

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012

Phase III Cyramza Trial Meets OS Primary Endpoint

September 26, 2014

Experts Concerned As Phase I Studies Reach Deeper Into Community Practice (Second story in a two-part series.)

April 2, 2010

Army Breast Cancer Program Seeks Grants Applicants

May 17, 1996